Edition:
United States

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

38.09USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$38.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
142,880
52-wk High
$46.12
52-wk Low
$15.74

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Natalie Holles

45 2018 President, Chief Operating Officer

Matthew Patterson

46 2018 Chief Executive Officer, Director

Thomas Schuetz

57 2013 Co-Founder, Independent Director

Thomas Soloway

50 2017 Chief Financial Officer, Senior Vice President

John Gray

54 2015 Senior Vice President - Research and Development, Chief Scientific Officer